264 related articles for article (PubMed ID: 3283461)
1. Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery.
Greeley WJ; Bushman GA; Kong DL; Oldham HN; Peterson MB
J Thorac Cardiovasc Surg; 1988 May; 95(5):842-9. PubMed ID: 3283461
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans.
Faymonville ME; Deby-Dupont G; Larbuisson R; Deby C; Bodson L; Limet R; Lamy M
J Thorac Cardiovasc Surg; 1986 Jun; 91(6):858-66. PubMed ID: 3520158
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
Watkins WD; Peterson MB; Kong DL; Kono K; Buckley MJ; Levine FH; Philbin DM
J Thorac Cardiovasc Surg; 1982 Aug; 84(2):250-6. PubMed ID: 6980332
[TBL] [Abstract][Full Text] [Related]
4. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease.
Komai H; Adatia IT; Elliott MJ; de Leval MR; Haworth SG
J Thorac Cardiovasc Surg; 1993 Sep; 106(3):473-8. PubMed ID: 8361190
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of prostacyclin and thromboxane in children before, during, and after cardiopulmonary bypass.
Fleming WH; Sarafian LB; Leuschen MP; Newland MC; Kennedy EM; Kugler JD; Chapin JW; Hurlbert BJ; Bolam DL; Nelson RM
J Thorac Cardiovasc Surg; 1986 Jul; 92(1):73-8. PubMed ID: 3755198
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease.
Turner-Gomes SO; Andrew M; Coles J; Trusler GA; Williams WG; Rabinovitch M
J Thorac Cardiovasc Surg; 1992 Jan; 103(1):87-97. PubMed ID: 1728719
[TBL] [Abstract][Full Text] [Related]
7. Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.
Fortier S; DeMaria RG; Lamarche Y; Malo O; Denault A; Desjardins F; Carrier M; Perrault LP
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):109-16. PubMed ID: 15224029
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery.
Schulze-Neick I; Li J; Penny DJ; Redington AN
J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1033-9. PubMed ID: 11385367
[TBL] [Abstract][Full Text] [Related]
9. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease.
Alvarez Kindelan A; Pérez Navero JL; Ibarra de la Rosa I; Concha Ruiz M; Montilla López P; Romanos Lezcano A
Crit Care Med; 1994 Nov; 22(11):1754-61. PubMed ID: 7956278
[TBL] [Abstract][Full Text] [Related]
10. Effect of experimental cardiopulmonary bypass on systemic and transcardiac thromboxane B2 levels.
Kobinia GS; LaRaia PJ; D'Ambra MN; Fabri BM; Aylesworth CA; Peterson MB; Watkins WD; Buckley MJ
J Thorac Cardiovasc Surg; 1986 Jun; 91(6):852-7. PubMed ID: 3754915
[TBL] [Abstract][Full Text] [Related]
11. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
[TBL] [Abstract][Full Text] [Related]
12. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
13. Cardiac prostacyclin kinetics during cardiopulmonary bypass.
Kobinia GS; LaRaia PJ; Peterson MB; D'Ambra MN; Watkins WD; Austen WG; Buckley MJ
J Thorac Cardiovasc Surg; 1984 Dec; 88(6):965-71. PubMed ID: 6389992
[TBL] [Abstract][Full Text] [Related]
14. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
Ylikorkala O; Saarela E; Viinikka L
J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass.
Finn A; Naik S; Klein N; Levinsky RJ; Strobel S; Elliott M
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):234-41. PubMed ID: 8429650
[TBL] [Abstract][Full Text] [Related]
16. Thrombomodulin and angiotensin-converting enzyme activity during pediatric open heart operations.
Komai H; Haworth SG
Ann Thorac Surg; 1996 Aug; 62(2):553-8. PubMed ID: 8694622
[TBL] [Abstract][Full Text] [Related]
17. Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrest.
Pearl JM; Schwartz SM; Nelson DP; Wagner CJ; Lyons JM; Bauer SM; Duffy JY
Ann Thorac Surg; 2004 Mar; 77(3):994-1000. PubMed ID: 14992914
[TBL] [Abstract][Full Text] [Related]
18. The hemodynamic effects of phenoxybenzamine in neonates, infants, and children.
Mossad E; Motta P; Sehmbey K; Toscana D
J Clin Anesth; 2008 Mar; 20(2):94-8. PubMed ID: 18410862
[TBL] [Abstract][Full Text] [Related]
19. The effect of modified ultrafiltration on the postoperative course in patients with congenital heart disease.
Gaynor JW
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2003; 6():128-39. PubMed ID: 12740779
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW
J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
